Get Adobe Flash player

Thalassaemia - a brief history

The thalassaemias are a group of disorders which affect the production of red blood cells. They are genetic disorders, that is, they may be passed from parent to child. Beta thalassaemia major is the commonest clinically significant form of thalassaemia. 

People who have beta thalassaemia major (hereafter referred to as "thalassaemia") will need medical treatment throughout their lives. It is very important for a person with thalassaemia to follow their treatment programme carefully. 

It is also important to remember that, although thalassaemia is a serious, lifelong medical disorder, with modern medical treatment it is manageable.
 

Children who are born with thalassaemia in the UK today should expect to reach their full educational potential, have careers, relationships and even healthy children of their own. They should expect to live a normal or near normal lifespan.

To find out more about the different types of thalassaemia and their  treatment  select a link from the menu.



videos

an image

A selection of educational videos for parents, patients and health care professionals  

web links

an image

Any advice offered through external message boards or web sites should be confirmed with a qualified professional before being acted upon.

If in doubt contact your GP or the UKTS.

pdf library

an image

Download all UKTS information from here.


Site search
Visitors
Thalassaemia across the world - Building a new map
The University College London in conjunction with Thalassamia International Federation offers the first academic course ever to health professional in Haemoglobinopathies.

North of England Project - UKTS is grateful for the support of the Roald Dahl’s Marvellous Children’s Charity; which is partially funding this project.

ITHAnet, - electronic infrastructure for thalassaemia research network. Visit the website and find out more

Patient health information

The European Organisation for Rare Diseases, EURORDIS, is a patient-driven alliance of patient organisations and individuals active in the field of rare diseases.

ENERCA is an acronym for European Network for Rare and Congenital Anaemias. It started back in 2002, funded by the European Commission, with the purpose of offering an improved public health service to professional medical practitioners and patients in every aspect of rare anaemias.

David Burrowes MP - Local MP helping to champion thalassaemia within the goverment (read more)